The University of Ottawa secured $3 million federal funding to lead infectious disease research enhancing Canada’s readiness for future pandemics. Similarly, the Global Virus Network initiated a multinational diagnostic assessment for mpox to strengthen global outbreak control. Dutch-Danish firm Rapidemic received $2.7 million from the Gates Foundation to advance rapid, ambient-temperature molecular diagnostics targeting sexually transmitted infections. These efforts represent critical investments in surveillance and rapid response capabilities for emerging infectious diseases worldwide.